Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Income Before Tax
Profit after all operating and non-operating items but before income tax.
Vivani Medical, Inc.NASDAQ: VANI
Income Before Tax · Q1 FY2026 · quarter ended Mar 2026
Income before tax remains negative
Q1 FY2026 income before tax was -$6.78M, compared with -$6.3M a year earlier. Trailing-twelve-month income before tax was -$27.09M.
Context
- Income before tax grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly income before tax holds near -$6.78M or moves back toward the trailing-twelve-month quarterly average of -$6.77M.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Before Tax history
USD · from the income statement
- Latest · FY2025
- (26.61M) USD
- Year-over-year change
- -13.3%
| Period | Period end | Income Before Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (26.61M) | -13.3% |
| FY2024 | 2024-12-31 | (23.49M) | +8.4% |
| FY2023 | 2023-12-31 | (25.65M) | -84.7% |
| FY2022 | 2022-12-31 | (13.89M) | -8.7% |
| FY2021 | 2021-12-31 | (12.77M) | — |
Income Before Tax vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -14.1% is the 5th highest of 8, against a peer median of -9.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $131.82M USD | +637.8% | — | — | |
| LTM Mar 2026 | $11.38M USD | -20.2% | -15.4% | 10.8% | |
| LTM Mar 2026 | -$14.21M USD | -21.8% | — | 13535.2% | |
| LTM Mar 2026 | -$27.09M USD | -14.1% | — | — | |
| LTM Mar 2026 | -$34.78M USD | +13.7% | — | 226.9% | |
| LTM Mar 2026 | -CA$36.38M CAD | -15.4% | — | — | |
| LTM Mar 2026 | -$45.35M USD | +20.5% | — | 62.7% | |
IMAImageneBio Inc | LTM Mar 2026 | -$45.4M USD | -9.3% | — | — |
| Peer median (excluding VANI) | — | -9.3% | -15.4% | 144.8% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 357K | 0 | 424K |
| Gross Profit | 0 | 0 | (357K) | 0 | (424K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 11M | 14.17M | 16.97M | 15.75M | 18.13M |
| Selling, General & Admin | 2.32M | 5.37M | 10M | 8.93M | 9.43M |
| Operating Expenses | 13.32M | 21.24M | 26.61M | 24.68M | 27.13M |
| Depreciation & Amortization | 345K | 381K | 357K | 400K | 424K |
| EBITDA | (12.43M) | (19.16M) | (25.3M) | (23.09M) | (26.19M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (13.32M) | (21.24M) | (26.97M) | (24.68M) | (27.56M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 550K | 7.35M | 1.31M | 1.19M | 947K |
| Income Before Tax | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (12.77M) | (13.89M) | (25.65M) | (23.49M) | (26.61M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| EPS (Diluted) | (0.33) | (0.17) | (0.50) | (0.43) | (0.43) |
| Weighted Avg Shares | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
| Weighted Avg Shares (Diluted) | 36.25M | 38.24M | 50.85M | 54.98M | 62.39M |
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.